These emerging treatments , including copyright , belong to a class of drugs called GLP-1 agents. Primarily developed for managing high blood sugar, they work by assisting the pancreas to secrete sufficient insulin and limiting increased blood sugar levels. Furthermore , their potential to encourage weight management has led to substantial interest